Platform
Features
0 followers
MISSION Therapeutics offers a platform for the development of small molecule drugs that selectively target deubiquitylating enzymes (DUBs).
Industries
Headquarters
Employees
Links
Anker Lundemose
10 members
9 members
8 members
4 members
3 members
Queen Mary University
5 followers
Genomics England
3 followers
Signum Biosciences
1 follower
Eupry
4 followers
QuellTX
Etiqa
The Academy of Medical Sciences
Oxford Nanopore Technologies
7 followers
Surfix
Flyer One Ventures
NMD Pharma
Explore companies